- Report
- May 2023
- 250 Pages
Global
From €4840EUR$5,000USD£4,165GBP
- Report
- February 2023
- 250 Pages
Global
From €4840EUR$5,000USD£4,165GBP
- Report
- April 2023
- 115 Pages
Global
From €4138EUR$4,275USD£3,561GBP
€4598EUR$4,750USD£3,957GBP
- Report
- October 2022
- 270 Pages
Global
From €3630EUR$3,750USD£3,124GBP
- Report
- September 2022
- 232 Pages
Global
From €3388EUR$3,500USD£2,915GBP
- Report
- August 2022
- 222 Pages
Global
From €3388EUR$3,500USD£2,915GBP
- Report
- December 2022
- 116 Pages
Global
From €4743EUR$4,900USD£4,082GBP
- Report
- June 2022
- 148 Pages
Global
From €2419EUR$2,499USD£2,082GBP
- Report
- March 2023
- 146 Pages
Global
From €5275EUR$5,450USD£4,540GBP
- Report
- May 2023
- 252 Pages
Global
From €3440EUR$3,554USD£2,961GBP
€3822EUR$3,949USD£3,289GBP
- Report
- April 2023
- 131 Pages
United States
From €3440EUR$3,554USD£2,961GBP
€3822EUR$3,949USD£3,289GBP
- Report
- October 2022
- 114 Pages
Global
From €4114EUR$4,250USD£3,540GBP
- Report
- August 2022
- 110 Pages
Global
From €4138EUR$4,275USD£3,561GBP
€4598EUR$4,750USD£3,957GBP
- Report
- June 2022
- 120 Pages
Global
From €4138EUR$4,275USD£3,561GBP
€4598EUR$4,750USD£3,957GBP
- Report
- May 2023
- 450 Pages
Global
From €4840EUR$5,000USD£4,165GBP
- Report
- April 2023
- 137 Pages
Global
From €7259EUR$7,500USD£6,247GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2662EUR$2,750USD£2,291GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2662EUR$2,750USD£2,291GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2662EUR$2,750USD£2,291GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2662EUR$2,750USD£2,291GBP

The Anti Tumour Necrosis Factor (anti-TNF) market is a subset of the Immune Disorders Drugs market. Anti-TNF drugs are used to treat a variety of immune-mediated diseases, such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. These drugs work by blocking the action of TNF, a protein that is involved in inflammation and tissue destruction. Anti-TNF drugs are generally administered as injections or infusions, and are often used in combination with other medications.
The anti-TNF market is highly competitive, with a number of companies offering products. These include AbbVie, Amgen, Janssen, Merck, Pfizer, and UCB. Each company has its own portfolio of anti-TNF drugs, and they are continually developing new products to meet the needs of patients. Show Less Read more